Intra-uterine injection of amnion-derived acellular bioscaffold product in mares, a description of systemic and intra-uterine effects over 21 days. Published in the Journal of Equine Veterinary Science Volume 142, November 2024, 105180 Title: Intra-uterine injection...
Dr. Lauren Schnabel says, “This finding supports our clinical observations over the last four years that these products are critical in wounds with substantial tissue loss and complicating factors such as underlying exposed bone and/or tendons in which the...
AniCell has developed a new all-natural regenerative amnion-based product for use in stallions with low sperm motility and semen count. We are taking applications until Friday, November 16th. The intravenous application of our amnion products has not resulted in a...
Intra-uterine injection of amnion-derived acellular bioscaffold product in mares Abstract from Clinical Theriogenology 2021; 13: 339 Title: Intra-uterine injection of amnion-derived acellular bioscaffold product in mares: systemic and intra-uterine effects over 21...
Abstract from American College of Veterinary Surgeons Study Submission Title: Acellular preserved or morselized liquid amnion accelerated bone regeneration in rams. Rivera-Barreno R1, Barceló-Fimbres M2, Bustamante-Montana E1, Hernandez A1, Rodríguez-Alarcon CA1,...
Barcelo-Fimbres M – Anicell Biotech LLC, Chandler, AZ, USA, Schnabel LV – North Carolina State University, NC, USA, Sorum M – Scottsdale Horse Vet, AZ, USA, Campos-Chillon LF – Cal Poly San Luis Obispo, CA, USA, Culp A – Anicell Biotech...
Beginning in February, AniCell began conducting Phase II Field Trial for certain indications (tendons, ligaments and joint inflammation) to better ascertain our products efficacy prior to our clinical trials coming up this summer. We have begun to collect our...